Phase 2 Study of Androgen Deprivation Therapy (ADT) Plus Chemotherapy as Initial Treatment for Local Failures or Advanced Prostate Cancer
Phase of Trial: Phase II
Latest Information Update: 15 May 2016
At a glance
- Drugs Degarelix (Primary) ; Doxorubicin; Estramustine; Ketoconazole
- Indications Prostate cancer
- Focus Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 12 Nov 2015 Planned End Date changed from 1 Oct 2023 to 1 Nov 2023 as reported by ClinicalTrials.gov.
- 12 Nov 2015 Planned primary completion date changed from 1 Oct 2020 to 1 Nov 2020 as reported by ClinicalTrials.gov.